pharmaceuticals
pharmaceuticals Articles
Threshold Pharmaceuticals watched its stock completely collapse in Monday’s session after a joint late-stage study failed to yield positive results.
Published:
Last Updated:
Idera Pharmaceuticals made a strong push in Monday’s session following the presentation of its clinical data over the weekend.
Published:
Last Updated:
MEI Pharma Inc. (NASDAQ: MEIP) was leading the bulls in the broad markets Monday on news of positive Phase 2 results. The company announced positive results from a study of its investigational drug...
Published:
Last Updated:
These biotech companies stood out from the rest with incredible gains or losses over the course of the past week.
Published:
Last Updated:
KaloBios Pharmaceuticals continues to vastly outperform the broad markets through December after Martin Shkreli took the helm.
Published:
Last Updated:
Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) was leading the bulls early in Thursday’s session on positive results from a Phase 2 study. The company announced positive top-line results from its Phase...
Published:
Last Updated:
InVivo Therapeutics announced a new strategy for the treatment of chronic spinal cord injury.
Published:
Last Updated:
It looks like Wednesday will be a huge day for Zafgen, considering the most recent development in the beloranib study.
Published:
Last Updated:
Aeterna Zentaris announced that it has finalized of a co-marketing agreement with Armune BioScience that will allow it to promote Armune’s Apifiny.
Published:
Last Updated:
Spark Therapeutics, Inc. (NASDAQ: ONCE) filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding a secondary offering. There were no pricing terms given regarding the...
Published:
Last Updated:
Arena Pharmaceuticals saw its shares jump in Monday’s session on news of an U.S. Food and Drug Administration (FDA) approval.
Published:
Last Updated:
Anavex Life Sciences announced the publication of further data for Anavex 3-71 in the peer-reviewed scientific journal Neurodegenerative Diseases.
Published:
Last Updated:
Pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk to a great amount of risk...
Published:
Last Updated:
Despite the howling from political candidates trying to make the top drug-makers their whipping boy in populist campaign efforts, the need and demand for pharmaceuticals will only continue. This...
Published:
Last Updated:
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had a very hard time getting off the ground from 2011 through the start of 2014. This is the world’s top generic drug maker, and shares have...
Published:
Last Updated: